0.2925
price down icon3.53%   -0.0107
after-market アフターアワーズ: .29 -0.0025 -0.85%
loading
前日終値:
$0.3032
開ける:
$0.308
24時間の取引高:
3.50M
Relative Volume:
1.28
時価総額:
$3.47M
収益:
-
当期純損益:
$-11.53M
株価収益率:
-0.0607
EPS:
-4.82
ネットキャッシュフロー:
$-11.12M
1週間 パフォーマンス:
+22.03%
1か月 パフォーマンス:
+27.51%
6か月 パフォーマンス:
-74.69%
1年 パフォーマンス:
-81.49%
1日の値動き範囲:
Value
$0.29
$0.3227
1週間の範囲:
Value
$0.24
$0.3448
52週間の値動き範囲:
Value
$0.15
$3.10

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name
名前
Processa Pharmaceuticals Inc
Name
セクター
Healthcare (1170)
Name
電話
443-776-3133
Name
住所
7380 COCA COLA DRIVE, HANOVER
Name
職員
13
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
PCSA's Discussions on Twitter

PCSA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.2925 2.85M 0 -11.53M -11.12M -4.82
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-04-25 開始されました H.C. Wainwright Buy

Processa Pharmaceuticals Inc (PCSA) 最新ニュース

pulisher
May 30, 2025

Processa Pharmaceuticals (PCSA) Highlights Cancer Drug Advances at ASCO 2025 | PCSA Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting | PCSA Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Processa Pharmaceuticals presents cancer drug advances at ASCO - Investing.com Australia

May 30, 2025
pulisher
May 30, 2025

Processa Pharmaceuticals Highlights Next Generation Cancer Therapies with Three Accepted Abstracts at 2025 ASCO Annual Meeting - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Latest Clinical Trial Data: Processa Presents 3 Cancer Treatment Breakthroughs at ASCO 2025 - Stock Titan

May 30, 2025
pulisher
May 24, 2025

Processa Pharmaceuticals (NASDAQ:PCSA) Stock Price Down 1.5% – What’s Next? - Defense World

May 24, 2025
pulisher
May 09, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price - MSN

May 09, 2025
pulisher
May 08, 2025

Processa Pharmaceuticals Announces Launch of Website (www.Necrobiosislipoidicastudy.com) to Increase Awareness of Ulcerative Necrobiosis Lipoidica and to Inform Patients of the ongoing Phase 2B Study of PCS499 - Barchart.com

May 08, 2025
pulisher
May 02, 2025

There is no way Processa Pharmaceuticals Inc (PCSA) can keep these numbers up - Sete News

May 02, 2025
pulisher
May 02, 2025

Processa Pharmaceuticals (PCSA) Expected to Announce Earnings on Friday - Defense World

May 02, 2025
pulisher
May 01, 2025

Processa Pharmaceuticals Inc: Rising -91.68% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

May 01, 2025
pulisher
Apr 30, 2025

Taking a Closer Look At Processa Pharmaceuticals Inc (PCSA) Following Its Recent Trade - knoxdaily.com

Apr 30, 2025
pulisher
Apr 24, 2025

Processa Pharmaceuticals Inc [PCSA] Shares Rise 8.43 % on Wednesday - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.65 - MSN

Apr 24, 2025
pulisher
Apr 22, 2025

Processa Pharmaceuticals Inc (PCSA) can make a big difference with a little luck - Sete News

Apr 22, 2025
pulisher
Apr 21, 2025

A Closer Look at Processa Pharmaceuticals Inc (PCSA) Stock Gains - investchronicle.com

Apr 21, 2025
pulisher
Apr 21, 2025

Recent Insider Activity Suggests Potential Gains for Processa Pharmaceuticals Inc (PCSA) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 15, 2025

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025 - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Project Optimus: Processa Unveils New Approach for Rare Disease Treatment Success - Stock Titan

Apr 15, 2025
pulisher
Apr 12, 2025

Data-Based Insights About Processa Pharmaceuticals Inc (PCSA) - stocksregister.com

Apr 12, 2025
pulisher
Apr 11, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.22 - Investing.com

Apr 11, 2025
pulisher
Apr 10, 2025

PCSA Stock Sees Decline of Approximately -11.67% in Last Five Days - knoxdaily.com

Apr 10, 2025
pulisher
Apr 02, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.36 - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.36 By Investing.com - Investing.com India

Apr 02, 2025
pulisher
Mar 28, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Friday - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 - Investing.com

Mar 25, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

Processa Pharmaceuticals Inc. (PCSA) reports earnings - qz.com

Mar 20, 2025
pulisher
Mar 18, 2025

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Cancer Therapy Innovator Processa Pharmaceuticals Opens Door to Investors at Elite MedInvest Conference - StockTitan

Mar 18, 2025
pulisher
Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 - Investing.com India

Mar 13, 2025
pulisher
Mar 11, 2025

Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals - Barchart

Mar 11, 2025
pulisher
Mar 04, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.46 - Investing.com

Mar 04, 2025
pulisher
Feb 28, 2025

Processa Pharma Stock Price, Quotes and Forecasts - Benzinga

Feb 28, 2025
pulisher
Feb 21, 2025

The Insider Secrets to Processa Pharmaceuticals: A Dark Horse in the Race - Elblog.pl

Feb 21, 2025
pulisher
Feb 21, 2025

Hidden Gems: Why Insiders Are Banking on Processa Pharmaceuticals - Bit Perfect Solutions

Feb 21, 2025
pulisher
Feb 21, 2025

Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 21, 2025
pulisher
Feb 20, 2025

10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 20, 2025
pulisher
Feb 13, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price By Investing.com - Investing.com Nigeria

Feb 13, 2025
pulisher
Feb 11, 2025

Processa Pharmaceuticals (NASDAQ:PCSA) Publishes Investor Presentation - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals IncOn Feb 4, Received Nasdaq Notice For Bid Price Non-Compliance - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Processa Pharmaceuticals Inc (PCSA) Shares Soar Above 1-Year High - The News Heater

Feb 10, 2025
pulisher
Feb 07, 2025

Processa Pharmaceuticals to Present at 2025 BIO CEO & Investor Conference - Nasdaq

Feb 07, 2025
pulisher
Feb 07, 2025

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference - GlobeNewswire

Feb 07, 2025
pulisher
Feb 07, 2025

Processa Pharma's Cancer Pipeline Takes Center Stage at Elite BIO Investor Conference - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

Gastroparesis Market Expected to rise, 2034 | Vanda - openPR

Feb 06, 2025
pulisher
Feb 03, 2025

Financial Analysis: Processa Pharmaceuticals Inc (PCSA)’s Ratios Unveil Key Insights - The Dwinnex

Feb 03, 2025

Processa Pharmaceuticals Inc (PCSA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):